PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2007
CASE
AUTH/2034/8/07 Recordati Pharmaceuticals

AUTH/2034/8/07: MHRA v Recordati β€” Tradorec XL leavepiece and prohibited β€˜MHRA advice’ reference

Recordati’s Tradorec XL leavepiece quoted β€˜MHRA advice’ on prescribing prolonged-release tramadol by brand. The Panel ruled this breached Clause 9.5: MHRA references…

2007
CASE
AUTH/2014/6/07 Pfizer

AUTH/2014/6/07: Consultant in Public Health v Pfizer – Promotion of Champix (varenicline) (No breach)

A PCT public health consultant alleged Pfizer’s Champix promotion was premature (pre-NICE), undermined local guidelines/NRT, and bypassed the stop smoking service. The…

2019
CASE
AUTH/3184/4/19 GW Pharmaceuticals

GW Pharmaceuticals website: Sativex claims without prescribing information and pre-licence promotion of Epidiolex (AUTH/3184/4/19)

GW’s HCP website pages were ruled promotional for Sativex but lacked required prescribing information, and its pipeline section was found to promote…

2006
CASE
AUTH/1909/11/06 AstraZeneca ⭐ Case of the Week

AUTH/1909/11/06: Medical Representative v AstraZeneca (Arrangements for meetings) – No breach

A medical representative alleged AstraZeneca meetings were visible to the public and that surgery meetings were fund-raising with no education. The PMCPA…

2006
CASE
AUTH/1840/5/06 GlaxoSmithKline

AUTH/1840/5/06: GSK restless legs syndrome (RLS) patient poster – no breach (Clauses 20.1, 20.2)

A PCT pharmacist challenged a GSK-sponsored RLS awareness poster in GP practices as misleading and indirect POM advertising. The PMCPA Panel found…

2009
CASE
AUTH/2286/12/09 GlaxoSmithKline

AUTH/2286/12/09: General Practitioner v GlaxoSmithKline β€” Sponsorship of drug testing in sport (Out of scope; no breach)

Complaint about GSK’s sponsorship of drug testing in sport. PMCPA found the matter outwith the scope of the ABPI Code; no breach.…

2011
CASE
AUTH/2446/10/11 Bayer

AUTH/2446/10/11: Anonymous v Bayer – alleged promotion of Levitra (outwith scope; no breach)

Anonymous complaint about alleged promotion of Levitra by Bayer. PMCPA recorded the matter as outwith the scope of the Code; no case…

2015
CASE
GlaxoSmithKline

GSK: β€˜Open, inhale, close’ device claim ruled misleading in Relvar digital sales aids; oversight concerns in pharmacist referral activity

GSK was found in breach for misleading β€œefficacy in 3 steps: Open Inhale Close” claims in Relvar digital sales aids and for…

2019
CASE
AUTH/3143/1/19 Ferring Pharmaceuticals ⭐ Case of the Week

Tillotts v Ferring: Cortiment leavepiece not withdrawn and misleading β€œgeneric budesonides” claim (AUTH/3143/1/19)

Ferring agreed in inter-company dialogue to withdraw a Cortiment leavepiece but it was still used at a conference weeks later. Panel found…

2019
CASE
AUTH/3199/5/19 Vifor Pharma

Vifor Pharma: breach of undertaking over Ferinject vs Monofer safety comparisons and medical information email (AUTH/3199/5/19)

PMCPA ruled Vifor breached undertakings by using materials and a medical information email that misleadingly compared Ferinject vs Monofer on hypersensitivity/ADRs, and…

2019
CASE
AUTH/3289/12/19 Bristol-Myers Squibb

Bristol Myers Squibb and Pfizer: Eliquis prescribing information in promotional email (AUTH/3289/12/19 & AUTH/3290/12/19)

Eliquis promotional email used July 2019 prescribing information after an Oct 2019 SPC update on reversal agent/overdose. Panel found PI content sufficient…

2019
CASE
Teva

Teva breached Clause 4.1 after DuoResp Spiromax prescribing information was hard to read in sponsored webinar

A UK health professional said DuoResp Spiromax prescribing information in a Teva-commissioned webinar was difficult to read. The Panel ruled the line…

2020
CASE
AUTH/3367/7/20 GlaxoSmithKline

GSK Duac banner ad on Pulse Today: complaint about missing prescribing information (AUTH/3367/7/20)

A UK health professional said a Duac online banner appeared static and lacked a one-click link to prescribing information. Panel found PI…

2020
CASE
AUTH/3332/4/20 Swedish Orphan Biovitrum ⭐ Case of the Week

AUTH/3332/4/20: Anonymous v Sobi β€” unsolicited MSL β€œmaking contact” email during COVID-19 (No breach)

Anonymous complaint about an unsolicited MSL email to an NHS address during COVID-19. Panel found the email was non-promotional, mirrored an approved…

2020
CASE
AUTH/3344/5/20 Britannia Pharmaceuticals

Britannia Pharmaceuticals: promotional email sent without consent and no robust unsubscribe process (AUTH/3344/5/20)

A health professional received a promotional Parkinson’s magazine by email despite asking to be removed from mailing lists. PMCPA found breaches for…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training